Вестник Ассоциации пульмонологов Центральной Азии Ҷилди 13 № 8 (2025) · Саҳифаҳои 203-209

FREQUENCY OF MYCOSES IN PATIENTS WITH TB-HIV

Babamatova H.U.

Дар манбаъ хондан PDF

Аннотатсия

Currently, one of the pressing problems of phthisiology remains the high incidence of tuberculosis among patients with HIV infection. The high frequency of multiple drug resistance of tuberculosis mycobacteria (resistance to the most effective anti-tuberculosis drugs isoniazid and rifampicin) clearly and directly correlates with the prevalence of HIV infection. The most common causative agents of mycoses are yeast-like fungi of the genus Candida and mycelial, mold fungi of the genera Aspergillus, Penicillium, Mucor, and some others. The fight against it is significantly complicated by the fact that there is a mutually aggravating synergy between tuberculosis and HIV: HIV infection contributes to the progression of tuberculosis infection, and tuberculosis worsens the course of HIV infection. Mycocenoses - associations of pathogens - are of great importance. The more pronounced the immunodeficiency, the more pronounced the manifestations of candidiasis.

tuberculosis, HIV, co-infection, mycoses, diagnosis

Манбаи метамаълумот: бойгонии OAI-PMH-и маҷалла · Sindex матни пурраро нигоҳ намедорад, ба манбаъ пайванд медиҳад.

Иқтибос гирифтан

APA 7
Babamatova H.U. (2025). FREQUENCY OF MYCOSES IN PATIENTS WITH TB-HIV. Вестник Ассоциации пульмонологов Центральной Азии, 13(8), 203-209.
GOST R 7.0.5
Babamatova H.U. FREQUENCY OF MYCOSES IN PATIENTS WITH TB-HIV // Вестник Ассоциации пульмонологов Центральной Азии. 2025. Т. 13. № 8. С. 203-209.
BibTeX
@article{h.u.2025,
  author  = {Babamatova H.U.},
  title   = {FREQUENCY OF MYCOSES IN PATIENTS WITH TB-HIV},
  journal = {Вестник Ассоциации пульмонологов Центральной Азии},
  year    = {2025},
  volume  = {13},
  number  = {8},
  pages   = {203-209}
}
RIS
TY  - JOUR
AU  - Babamatova H.U.
TI  - FREQUENCY OF MYCOSES IN PATIENTS WITH TB-HIV
JO  - Вестник Ассоциации пульмонологов Центральной Азии
PY  - 2025
VL  - 13
IS  - 8
SP  - 203
EP  - 209
ER  -